Plasma levels of von Willebrand factor, endothelin-1, prostacyclin and thromboxane in children from families with high risk of premature coronary artery disease

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 61, Issue 4, 2001, Pages 317-323

  Wojakowski, W ^a   Gminski J ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

CHD risk factors; Children; Endothelial injury; Premature CHD

Indexed keywords

ENDOTHELIN 1; PROSTACYCLIN; THROMBOXANE; VON WILLEBRAND FACTOR;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CARDIOVASCULAR RISK; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE MARKER; FAMILY HISTORY; FEMALE; HIGH RISK POPULATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MALE; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT;

6-KETOPROSTAGLANDIN F1 ALPHA; ADOLESCENT; CHILD; CHILD, PRESCHOOL; CORONARY ARTERIOSCLEROSIS; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; EPOPROSTENOL; FAMILY HEALTH; FEMALE; HUMANS; MALE; RISK FACTORS; THROMBOXANE B2; VON WILLEBRAND FACTOR;

EID: 0034971420     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365510152379058     Document Type: Article

References (38)

1. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology
2. Parental history is an independent risk factor for coronary artery disease: The Framingham Study
3. Genetic-epidemiologic study of early-onset ischaemic heart disease
4. The expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II)
5. Lipid and apolipoprotein predictors of atherosclerosis in youth
6. Flow-mediated dilation in 9-11 year-old children. The influence of intrauterine and childhood factors
7. Circulating markers of inflammation for vascular risk prediction. Are they ready for prime time
8. Novel inflammatory markers of coronary risk. Theory versus practice
9. Primary prevention of coronary heart disease. Integrating risk assessement with intervention
10. The serum levels of soluble ICAM-1, VCAM-1 and E-selectin in children from families with the high risk of atherosclerosis
11. Evaluation of elastin metabolism in children from families with high risk of atherosclerosis
12. Atherosclerosis - An inflammatory disease
13. Wspólłistnienie innych czynników ryzyka miażdżycy u młodzieży z nadciśnieniem tȩtniczym
14. Wystȩpowanie czynników zagrożenia miażdżyca̧, u dzieci śla̧skich w wieku szkolnym
15. Potential markers of the atherosclerotic process in high-risk children
16. Von Willebrand factor. A marker for endothelial damage?
17. Vascular endothelial cell activation associated with increased plasma asymmetric dimethyl arginine in children and young adults with hypertension: A basis for atheroma?
18. Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis
19. Von Willebrand factor, endothelial cell damage and atherosclerosis
20. Von Willebrand factor and endothelial damage in essential hypertension
21. Soluble adhesion molecule P-selectin and endothelial dysfunction in essential hypertension: Implications for atherogenesis? A preliminary report
22. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris
23. Factor VIII, ABO blood group and the incidence of ischaemic heart disease
24. Prospective study of hemostatic factors and incidence of coronary heart disease. The ARIC Study
25. Von Willebrand factor, C-reactive protein and 5-year mortality in diabetic and nondiabetic subjects. The Hoorn study
26. Influence of puberty on endothelial dysfunction and oxidative stress in young patients with type 1 diabetes
27. Low level of prostacyclin as a risk of ischaemic heart disease
28. Plasma endothelin-1 like immunoreactivity levels in neonates
29. Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans
30. Role of endothelin in the increased vascular tone of patients with essential hypertension
31. Increased plasma endothelin level in patients with essential hypertension
32. Plasma endothelin in coronary venous blood from patients with either stable or unstable angina
33. Circulating immunoreactive endothelin in ischaemic heart disease
34. Plasma endothelin in human essential hypertension
35. Plasma endothelin-1 levels neither increase nor correlate with neurological scores, stroke risk factors, or outcome in patients with ischaemic stroke
36. Endothelial activation in patients with cardiac syndrome X
37. Balance of prostacyclin and thromboxane in offspring of parents with premature coronary arterial disease